EHMTI-0102. Prospective analysis of the use of onabotulinumtoxina (botox®) In the treatment of chronic migraine; real-life data in 299 patients from hull, UK

Detalles Bibliográficos
Autores principales: Khalil, M, Zafar, H, Quarshie, V, Ahmed, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2014
Materias:
Meeting Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182226/
http://dx.doi.org/10.1186/1129-2377-15-S1-G19
_version_ 1782337498557448192
author Khalil, M
Zafar, H
Quarshie, V
Ahmed, F
author_facet Khalil, M
Zafar, H
Quarshie, V
Ahmed, F
author_sort Khalil, M
collection PubMed
description
format Online
Article
Text
id pubmed-4182226
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer
record_format MEDLINE/PubMed
spelling pubmed-41822262014-10-02 EHMTI-0102. Prospective analysis of the use of onabotulinumtoxina (botox®) In the treatment of chronic migraine; real-life data in 299 patients from hull, UK Khalil, M Zafar, H Quarshie, V Ahmed, F J Headache Pain Meeting Abstract Springer 2014 2014-09-18 /pmc/articles/PMC4182226/ http://dx.doi.org/10.1186/1129-2377-15-S1-G19 Text en Copyright © 2014 Khalil et al; licensee Springer. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Abstract
Khalil, M
Zafar, H
Quarshie, V
Ahmed, F
EHMTI-0102. Prospective analysis of the use of onabotulinumtoxina (botox®) In the treatment of chronic migraine; real-life data in 299 patients from hull, UK
title EHMTI-0102. Prospective analysis of the use of onabotulinumtoxina (botox®) In the treatment of chronic migraine; real-life data in 299 patients from hull, UK
title_full EHMTI-0102. Prospective analysis of the use of onabotulinumtoxina (botox®) In the treatment of chronic migraine; real-life data in 299 patients from hull, UK
title_fullStr EHMTI-0102. Prospective analysis of the use of onabotulinumtoxina (botox®) In the treatment of chronic migraine; real-life data in 299 patients from hull, UK
title_full_unstemmed EHMTI-0102. Prospective analysis of the use of onabotulinumtoxina (botox®) In the treatment of chronic migraine; real-life data in 299 patients from hull, UK
title_short EHMTI-0102. Prospective analysis of the use of onabotulinumtoxina (botox®) In the treatment of chronic migraine; real-life data in 299 patients from hull, UK
title_sort ehmti-0102. prospective analysis of the use of onabotulinumtoxina (botox®) in the treatment of chronic migraine; real-life data in 299 patients from hull, uk
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182226/
http://dx.doi.org/10.1186/1129-2377-15-S1-G19
work_keys_str_mv AT khalilm ehmti0102prospectiveanalysisoftheuseofonabotulinumtoxinabotoxinthetreatmentofchronicmigrainereallifedatain299patientsfromhulluk
AT zafarh ehmti0102prospectiveanalysisoftheuseofonabotulinumtoxinabotoxinthetreatmentofchronicmigrainereallifedatain299patientsfromhulluk
AT quarshiev ehmti0102prospectiveanalysisoftheuseofonabotulinumtoxinabotoxinthetreatmentofchronicmigrainereallifedatain299patientsfromhulluk
AT ahmedf ehmti0102prospectiveanalysisoftheuseofonabotulinumtoxinabotoxinthetreatmentofchronicmigrainereallifedatain299patientsfromhulluk

Ejemplares similares